1. Signaling Pathways
  2. Cell Cycle/DNA Damage
    Stem Cell/Wnt
  3. Casein Kinase
  4. Casein Kinase Inhibitors

Casein Kinase Inhibitors

CK1

CK2

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

Casein Kinase Degraders, Inhibitors & Chemicals
Product Name CK1 CK2 Purity
IWP-2
CK1γ2, IC50: 40 nM
  99.93%
Silmitasertib  
CK2α, IC50: 1 nM
CK2α', IC50: 1 nM
99.94%
Emodin  
CK2α Wild-type, IC50: 5.9 μM (at ATP concentration is 50 μM)
CK2α Wild-type, IC50: 1.4 μM (at ATP concentration is 10 μM)
99.25%
Ellagic acid  
CK2, IC50: 40 nM
99.75%
Casein kinase 1δ-IN-18
CK1δ
 
CK1δ-IN-3
CK1δ
 
D4476
CK1, IC50: 0.3 μM
  99.94%
PF-670462 dihydrochloride
CK1δ, IC50: 14 nM
  99.96%
Silmitasertib sodium salt  
CK2α, IC50: 1 nM
CK2α', IC50: 1 nM
99.92%
TBB  
CK2, IC50: 0.15 μM (Human CK2)
98.54%
BTX-A51
CK1α/CSNK1A1
  98.58%
TMX-4116
CK1α
  99.76%
FPFT-2216
CK1α
  99.75%
SR-3029
CK1δ, IC50: 44 nM
  99.73%
PF-4800567
CK1δ, IC50: 711 nM
  99.69%
DMAT  
CK2, IC50: 0.13 μM (Human CK2)
98.09%
IC261
CK1δ, IC50: 1 μM
CK1α1, IC50: 16 μM
  99.63%
SGC-CK2-1  
CK2α, IC50: 36 nM
CK2α', IC50: 16 nM
99.67%
LY294002 hydrochloride  
CK2α2, IC50: 3.869 μM
CK2, IC50: 0.098 μM
99.93%
AMG-548 dihydrochloride
CK1
  99.86%
TAK-715
CK1γ2
CK1ε
  99.76%
PF-5006739
CK1γ2, IC50: 3.9 nM
  99.56%
CKI-7 free base
CK1, IC50: 6 μM
CK1, Ki: 8.5 μM
  99.80%
BioE-1115  
CK2α, IC50: 10 μM
99.56%
TTP 22  
CK2, IC50: 100 nM
98.40%
DEG-77
CK1α, DC50: 10 nM
  99.03%
MU1742
CK1δ
  99.74%
CK2/ERK8-IN-1  
CK2, IC50: 0.5 μM
CK2, Ki: 0.25 μM
≥99.0%
Hematein  
CKII, IC50: 0.74 μM
CK1-IN-1
CK1ε, IC50: 16 nM
CK1δ, IC50: 15 nM
  99.19%
Casein Kinase 2 Substrate Peptide  
CK2
98.47%
TA-01
CK1δ, IC50: 6.8 nM
  99.86%
TBCA  
CK2, IC50: 110 nM
CK2, Ki: 77 nM
99.45%
CK2 inhibitor 2  
CK2, IC50: 0.66 nM
98.51%
CK1-IN-2
CK1α/CSNK1A1, IC50: 123 nM
  99.54%
ON 108600  
CK2α2, IC50: 0.005 μM
CK2α1, IC50: 0.05 μM
99.73%
Longdaysin
CK1δ, IC50: 8.8 μM
CK1α/CSNK1A1, IC50: 5.6 μM
  99.83%
LH846
CK1δ, IC50: 290 nM
CK1α/CSNK1A1, IC50: 2.5 μM
  98.18%
Casein Kinase inhibitor A86
CK1α/CSNK1A1
  99.26%
SRPIN803  
CK2, IC50: 203 nM
99.17%
PI-828  
CK2α2, IC50: 1.127 μM
CK2, IC50: 149 nM
99.62%
BRD4/CK2-IN-1  
CK2, IC50: 230 nM
98.21%
TMX-4113
CK1α
  99.08%
Quinalizarin  
CK2, IC50: 110 nM
CK2, Ki: ~50 nM
MRT00033659
CK1δ, IC50: 0.9 μM
  99.77%
NCC007
CK1δ, IC50: 3.6 μM
CK1α/CSNK1A1, IC50: 1.8 μM
  99.22%
AMG-548
CK1
  ≥99.0%
(R)-DRF053 dihydrochloride
CK1, IC50: 14 nM
  99.30%
A-3 hydrochloride
CK1, Ki: 80 μM
CK2, Ki: 5.1 μM
99.75%
Casein kinase 1δ-IN-1
CK1δ
  99.91%
MGD-28
CK1α, DC50: 7.8 nM
  99.73%
SR-1277
CK1δ, IC50: 49 nM
 
CK2-IN-3  
CK2α, IC50: 1.51 μM
CK2α', IC50: 7.64 μM
CK2-IN-13  
CK2, IC50: 5.8 nM
TID43  
CK2, IC50: 0.3 μM
Casein kinase 1δ-IN-3
CK1δ, pIC50: 6.5376 M
  99.93%
IQA  
CK2
Casein kinase 1δ-IN-4
CK1γ2
  ≥98.0%
Casein kinase 1δ-IN-15
CK1γ2, IC50: 0.045 μM
 
Casein kinase 1δ-IN-27
CK1γ2, IC50: 16.5 nM
CK1ε, IC50: 9.41 nM
CK1α, IC50: 22 nM
 
SR-4133
CK1γ2, IC50: 10 μM
CK1ε, IC50: 58 nM
 
CK2/PIM1-IN-1  
CK2, IC50: 3.787 μM
HDAC/CK2-IN-1  
CK2, IC50: 3.67 μM
CK1-IN-3
CK1γ2, IC50: 2.22 μM
  99.00%
CK1δ-IN-10
CK1γ2, IC50: 0.255 μM
 
CK1-IN-4
CK1δ, IC50: 2.74 μM
 
CK2 inhibitor 3  
CK2, IC50: 280 nM
Casein kinase 1δ-IN-28
CK1ε, IC50: 14.6 nM
 
Ellagic acid (hydrate)  
CK2, IC50: 40 nM
CK2, Ki: 20 nM
Casein kinase 1δ-IN-10
CK1γ2
 
Casein kinase 1δ-IN-29
CK1ε, IC50: 0.447 μM
CK1δ, IC50: 0.005 μM
 
WAY-606344
CK1γ2
 
Casein kinase 1δ-IN-9
CK1γ2
  ≥98.0%
Emodin (Standard)  
CK2α Wild-type
Multi-kinase-IN-6  
CK2, IC50: 0.09 μM
TMCB  
CK2α, Ki: 83 nM
CK2α', Ki: 21 nM
QXG-6442
CK1α, DC50: 5.7 nM
 
PIM-1/CK2-IN-2  
CK2
p38α inhibitor 8
CK1γ2, IC50: 0.202 μM
 
CKI-7
CK1, IC50: 6 μM
CK1, Ki: 8.5 μM
 
CK2-IN-14  
CK2, IC50: 0.66 nM
Casein Kinase II Receptor Peptide  
CK2, Km: 500 μM
Casein kinase 1δ-IN-31
CK1γ2, IC50: 17 nM
CK1α, IC50: 196 nM
 
Casein kinase 1δ-IN-17
CK1δ
 
GSK-3β/CK-1δ-IN-1
CK1γ3, IC50: 0.57 μM
 
CK1δ-IN-9
CK1δ, IC50: 1.4 nM
 
AMG-548 hydrochloride
CK1
 
EGFR-IN-57  
CK2α, IC50: 0.171 μM
CK2 inhibitor 4  
CK2, IC50: 3.8 μM
4,5,6,7-Tetrabromo-1H-benzimidazole  
CK2
Casein kinase 1δ-IN-16
CK1δ
 
Casein kinase 1δ-IN-5
CK1γ2, IC50: 47 nM
 
CK2-IN-12  
CK2, IC50: 0.8 μM
CSNK2-IN-2  
CK2